000
| 02955nam 2200541zi 4500 |
---|
001 | 9.930019 |
---|
003 | CaOODSP |
---|
005 | 20240208082620 |
---|
006 | m o d f |
---|
007 | cr mn||||||||| |
---|
008 | 231106t20232023onc ob f000 0 eng d |
---|
020 | |a9780660687131 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
045 | |ay2y2 |
---|
086 | 1 |aHP5-174/2023E-PDF |
---|
245 | 00|aChildhood COVID-19 Immunization Coverage Survey (CCICS), 2023 : |bmethodological report / |cprepared for the Public Health Agency of Canada. |
---|
264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2023. |
---|
264 | 4|c©2023 |
---|
300 | |a1 online resource (50 pages) + |esummary (4 pages) + data tables (76 unnumbered pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Enquête sur la couverture vaccinale des enfants contre la COVID-19 (ECVEC), 2023 : rapport méthodologique. |
---|
500 | |a"Supplier name: Advanis Inc." |
---|
500 | |a"Contract number: 6D142-22611." |
---|
500 | |a"Registration number: POR 130-22." |
---|
500 | |a"November 2023"--Page 4. |
---|
504 | |aIncludes bibliographical references. |
---|
650 | 0|aCOVID-19 (Disease)|xVaccination|zCanada|xPublic opinion. |
---|
650 | 0|aCOVID-19 vaccines|zCanada|xPublic opinion. |
---|
650 | 0|aInfluenza|xVaccination|zCanada|xPublic opinion. |
---|
650 | 0|aInfluenza vaccines|zCanada|xPublic opinion. |
---|
650 | 0|aVaccination of children|zCanada|xPublic opinion. |
---|
650 | 0|aPublic opinion|zCanada. |
---|
650 | 0|aParents|zCanada|xAttitudes. |
---|
710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
---|
710 | 2 |aAdvanis (Firm), |econsultant. |
---|
775 | 08|tEnquête sur la couverture vaccinale des enfants contre la COVID-19 (ECVEC), 2023 : |w(CaOODSP)9.930020 |
---|
795 | |t2022 Childhood COVID-19 Immunization Coverage Survey : |w9.914600 |
---|
856 | 40|qPDF|s776 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-174-2023-eng.pdf|z(methodological report) |
---|
856 | 40|qPDF|s229 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-174-2023-1-eng.pdf|z(executive summary) |
---|
856 | 40|qPDF|s1.39 MB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-174-2023-2-eng.pdf|z(data tables) |
---|
856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2023/130-22-e/POR130-22-report.html|z(methodological report) |
---|
856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2023/130-22-e/summary/POR130-22-summary.html|z(executive summary) |
---|
856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2023/130-22-e/index.html|z(complete dataset) |
---|